Carbon monoxide (CO) serves as a source of energy and carbon for a diverse set of microbes found in anaerobic and aerobic environments. The enzymes that bacteria and archaea use to oxidize CO depend upon complex metallocofactors that require accessory proteins for assembly and proper function.
RcoM,
a heme-containing, CO-sensing transcription factor, is one
of two known bacterial regulators of CO metabolism. Unlike its analogue
CooA, the structure and DNA-binding properties of RcoM remain largely
uncharacterized. Using a combination of size exclusion chromatography
and sedimentation equilibrium, we demonstrate that RcoM-1 from Paraburkholderia xenovorans is a dimer, wherein the
heme-binding domain mediates dimerization. Using bioinformatics, we
show that RcoM is found in three distinct genomic contexts, in accordance
with the previous literature. We propose a refined consensus DNA-binding
sequence for RcoM based on sequence alignments of coxM-associated promoters. The RcoM promoter consensus sequence bears
two well-conserved direct repeats, consistent with other LytTR domain-containing
transcription factors. In addition, there is a third, moderately conserved
direct repeat site. Surprisingly, PxRcoM-1 requires
all three repeat sites to cooperatively bind DNA with a [P]1/2 of 250 ± 10 nM and an average Hill coefficient, n, of 1.7 ± 0.1. The paralog PxRcoM-2
binds to the same triplet motif with comparable affinity and cooperativity.
Considering this unusual DNA binding stoichiometry, that is, a dimeric
protein with a triplet DNA repeat-binding site, we hypothesize that
RcoM interacts with DNA in a manner distinct from other LytTR domain-containing
transcription factors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.